add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Receive Indications in Europe for ...PharmiWeb.com (press release) - Nov 5, 2009 Abbott's market-leading XIENCE V drug eluting stent is commerciallyavailable in the United States, Europe and other international markets. ... Bayer expands in medical technology with PolyBioMed buyPlastics News - Nov 19, 2009 PolyBioMed will give BMS access to uses such as coronary drug-eluting stents plus catheter systems for interventional cardiology, urology and neurology. ... HHS subpoenas Boston Scientific's CRM divisionMass Device - Nov 6, 2009 Taxus sales have declined significantly over the past two years as competition has stiffened from other drug-eluting stent makers like Medtronic or Johnson ... Updated guidelines recommended regarding percutaneous treatment of unprotected ...Cardiology Today - Nov 2, 2009 A collection of clinical evidence cited in a white paper suggested that percutaneous coronary intervention using drug-eluting stents may be an equally ... Association Between Higher Carotid Arterial Stenting Rates And Poorer Clinical ...Ethio Planet News - Nov 11, 2009 ... has researched the impact of cardiac devices, including drug-eluting stents and implantable cardioverter-defibrillators, for more than 15 years, ... Ireland's Medical Technology IndustryMedical Device Link (press release) - Nov 16, 2009 ... Boston Scientific (www.bostonscientific.com) invested in Irish expertise when it acquired Labcoat Ltd, a development stage drug-eluting stent technology ... Bayer MaterialScience Aquires PolyBioMedPharmaceutical Business Review - Nov 18, 2009 Reportedly, the acquisition gives Bayer MaterialScience access to application areas such as coronary drug-eluting stents plus catheter systems for ... The tiny tube that helps men beat impotenceDaily Mail - - Nov 2, 2009 To get round this, the trials will use newer generation drug-eluting stents. These release a medicine that dampens down the rapid healing process and keeps ... OPTIMUS-3: Prasugrel bested off-label doses of clopidogrel in small population ...Endocrine Today - Nov 16, 2009 ... indication for clopidogrel therapy (more than 12 months after an acute coronary event or bare metal stent placement and no drug-eluting stent in place). ... What is the appropriate use of chronic medications in the perioperative setting?The Hospitalist Online - - Nov 5, 2009 ... be delayed to permit completion of clopidogrel therapy—30 to 45 days after implantation of a bare-metal stent and 365 days after a drug-eluting stent. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
